With the increasing number of patients surviving after therapeutic interven
tion for congenital heart disease (CHD), accurate and frequent follow-up of
their morphologic and functional cardiovascular status is required, prefer
ably with a noninvasive imaging technique.
Echocardiography, either transthoracic or transesophageal, has been the fir
st choice for this purpose, and will probably keep that status, at least in
a large segment of the CHD spectrum. Magnetic resonance imaging (MRI) is a
n established method for high-resolution visualization of cardiovascular mo
rphology. In the past decade, newer MRI techniques have been developed that
allow functional evaluation of CHD patients. Particularly the introduction
of breath-hold imaging, contrast-enhanced MRA and user-friendly computer s
oftware for image analysis may move functional MRI of CHD from the science
laboratory to clinical use. It is already evident that MRI is superior to e
chocardiography in certain areas of limited echocardiographic access, such
as the pulmonary artery branches and the aortic arch in adult patients. But
MRI has also a unique potential for accurate volumetric analysis of ventri
cular function and cardiovascular blood flow, without any geometric assumpt
ions. If supported by increased cooperation between cardiologists and radio
logists, MRI will grow into a useful noninvasive imaging tool that, togethe
r with echocardiography, will obviate the need for invasive catheter studie
s for diagnostic purposes.